FdaApplication
BLA 761145
Identifiers
- fda_app_no: BLA761145
Properties
| Property | Value |
|---|---|
| applicant_name | Janssen Biotech, Inc. |
| application_type | BLA |
| approval_date | 2020-05-01 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DARZALEX FASPRO | DARATUMUMAB AND HYALURONIDASE-FIHJ | 120MG | Injection |
1 product